MXCT

MAXCYTE INC

MXCT·57777K106·US·Common Stock·Healthcare - Medical Devices-Activist

MXCT (MAXCYTE INC) is held by 87 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($6.2M), VANGUARD CAPITAL MANAGEMENT LLC ($2.8M), MORGAN STANLEY ($2.6M). Net institutional sentiment: Mixed.

87
Holders
Avg rating(25 Elite)
$26.8M
Total Value
52% (94)
Fund Consensus
41 buying - 38 selling
MXCTSmart Money Verdict
View all
Held by 87 funds
25 elite
Who's Trading
ActivistRGRIVER GLOBAL INVESTORS LLP6.1%May 14, 2026
ActivistMFMirabella Financial Services LLP0.0%Apr 10, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
InsiderSJSwirsky Douglas JSell $8KMar 17, 2026
ActivistCACadian Capital Management, LP3.5%Feb 17, 2026
ActivistCMCapricorn Fund Managers Ltd7.7%Feb 5, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.6%Jan 21, 2026
InsiderECErck Stanley CBuy $137KAug 13, 2025
InsiderDRDOUGLAS RICHARDBuy $111KAug 13, 2025
InsiderMMMasoud MaherBuy $103KAug 13, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
8.8M(-4.8%)$6.2M0.0%-64.15%
0
New
4M$2.8M0.0%+75.00%
36
Decreased
3.7M(-16.8%)$2.6M0.0%-61.71%
0
Unchanged
2.8M$1.9M0.0%-14.74%
0
Decreased
2.4M(-6.2%)$1.7M0.0%-79.49%
0
Decreased
2.2M(-7.0%)$1.5M0.0%-69.24%
0
Increased
2M(+153.3%)$1.4M0.0%-14.89%
41
Increased
1.2M(+1199.5%)$857,8810.0%+53.17%
40
Increased
1.2M(+144.9%)$814,2110.0%-24.71%
40
New
889,240$625,1360.0%+75.00%
37
Increased
799,709(+7.2%)$561,7960.0%-84.15%
26
Decreased
776,224(-24.5%)$545,2970.0%-14.74%
0
New
643,206$452,1740.0%+75.00%
33
Increased
608,162(+591.7%)$427,2340.0%+51.88%
39
Decreased
502,646(-48.0%)$352,8880.0%-62.53%
0
Increased
403,937(+18.3%)$283,7660.0%-79.94%
27
Decreased
386,667(-0.8%)$271,6340.0%-78.78%
0
Decreased
333,088(-77.6%)$233,9940.0%-37.96%
0
Decreased
328,651(-11.1%)$230,8770.0%-78.45%
0
Unchanged
307,987$216,3610.0%-87.59%
0

Showing 1-20 of 94

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used